Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant
- PMID: 37962657
- DOI: 10.1001/jama.2023.18022
Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant
Comment in
-
Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant-Reply.JAMA. 2023 Nov 14;330(18):1803-1804. doi: 10.1001/jama.2023.18025. JAMA. 2023. PMID: 37962654 No abstract available.
Comment on
-
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.JAMA. 2023 Jul 3;330(1):33-42. doi: 10.1001/jama.2023.9106. JAMA. 2023. PMID: 37279999 Free PMC article.